HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,119,445 | +69.9% | 9,837 | -7.7% | 0.01% | +66.7% |
| Q3 2022 | $659,000 | -24.2% | 10,653 | -2.2% | 0.00% | -25.0% |
| Q2 2022 | $869,000 | -28.1% | 10,895 | -5.1% | 0.00% | -20.0% |
| Q1 2022 | $1,208,000 | -38.5% | 11,480 | -37.0% | 0.01% | -37.5% |
| Q4 2021 | $1,963,000 | -50.4% | 18,221 | -49.5% | 0.01% | -52.9% |
| Q3 2021 | $3,954,000 | +4.8% | 36,095 | -10.4% | 0.02% | 0.0% |
| Q2 2021 | $3,772,000 | -45.7% | 40,286 | -46.6% | 0.02% | +6.2% |
| Q1 2021 | $6,946,000 | +128.9% | 75,476 | +81.4% | 0.02% | +6.7% |
| Q4 2020 | $3,035,000 | +8.6% | 41,604 | +15.7% | 0.02% | 0.0% |
| Q3 2020 | $2,794,000 | +3.5% | 35,970 | -26.0% | 0.02% | -6.2% |
| Q2 2020 | $2,700,000 | +259.0% | 48,576 | +91.4% | 0.02% | +220.0% |
| Q1 2020 | $752,000 | +123.8% | 25,375 | +173.6% | 0.01% | +150.0% |
| Q4 2019 | $336,000 | +29.7% | 9,275 | -2.4% | 0.00% | +100.0% |
| Q3 2019 | $259,000 | +1.2% | 9,504 | -10.8% | 0.00% | 0.0% |
| Q2 2019 | $256,000 | – | 10,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |